2023 Q1 Form 10-K Financial Statement

#000149315223009604 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $130.0K $500.0K
YoY Change 4.0% 0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.060M $4.050M $13.69M
YoY Change 6.56% 54.01% 25.74%
% of Gross Profit
Research & Development $2.620M $3.000M $11.73M
YoY Change -15.37% 0.46% 10.49%
% of Gross Profit
Depreciation & Amortization $192.7K $220.0K $731.6K
YoY Change 10.74% 37.35% 4.08%
% of Gross Profit
Operating Expenses $5.684M $7.050M $25.42M
YoY Change -4.73% 25.54% 18.2%
Operating Profit -$5.684M -$24.92M
YoY Change -2.7% 18.63%
Interest Expense $90.00K $100.0K $5.029M
YoY Change -101.94% -210.94% -999.77%
% of Operating Profit
Other Income/Expense, Net $93.09K $5.400M -$12.54M
YoY Change 5071.39% 176.59% -872.44%
Pretax Income -$5.590M -$14.80M -$37.47M
YoY Change -46.63% 164.06% 69.12%
Income Tax -$1.570M -$1.567M
% Of Pretax Income
Net Earnings -$5.591M -$13.23M -$35.90M
YoY Change -46.62% 213.41% 72.84%
Net Earnings / Revenue -10176.92% -7179.65%
Basic Earnings Per Share -$0.68 -$5.03
Diluted Earnings Per Share -$0.68 -$1.52 -$5.03
COMMON SHARES
Basic Shares Outstanding 9.090M shares 7.434M shares 7.143M shares
Diluted Shares Outstanding 8.281M shares 7.143M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.18M $32.75M $34.25M
YoY Change -24.52% -33.7% -30.65%
Cash & Equivalents $10.40M $11.49M $11.49M
Short-Term Investments $20.78M $21.25M $22.75M
Other Short-Term Assets $2.790M $2.780M $2.780M
YoY Change 9.63% 13.59% 13.59%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $36.33M $37.15M $37.15M
YoY Change -17.18% -28.47% -28.48%
LONG-TERM ASSETS
Property, Plant & Equipment $555.9K $548.3K $700.0K
YoY Change -47.05% 14.95% -40.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.750M $4.500M $4.500M
YoY Change -37.5% -25.0% -25.0%
Other Assets $5.218M $6.273M $1.620M
YoY Change 8780.23% -70.99% 3.39%
Total Long-Term Assets $5.774M $6.821M $6.830M
YoY Change -71.8% -69.14% -69.1%
TOTAL ASSETS
Total Short-Term Assets $36.33M $37.15M $37.15M
Total Long-Term Assets $5.774M $6.821M $6.830M
Total Assets $42.11M $43.98M $43.98M
YoY Change -34.56% -40.61% -40.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.973M $3.587M $3.590M
YoY Change 14.39% 40.8% 40.94%
Accrued Expenses $3.914M $4.795M $5.030M
YoY Change 39.78% 51.09% 35.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.180M $1.420M $1.420M
YoY Change
Total Short-Term Liabilities $10.42M $10.04M $10.04M
YoY Change 56.7% 48.27% 48.31%
LONG-TERM LIABILITIES
Long-Term Debt $3.900M $4.610M $4.610M
YoY Change -33.9% -21.26% -21.26%
Other Long-Term Liabilities $1.140M $0.00 $0.00
YoY Change -79.38% -100.0% -100.0%
Total Long-Term Liabilities $5.040M $4.610M $4.610M
YoY Change -55.9% -59.85% -59.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.42M $10.04M $10.04M
Total Long-Term Liabilities $5.040M $4.610M $4.610M
Total Liabilities $15.46M $14.65M $14.65M
YoY Change -14.48% -19.74% -19.73%
SHAREHOLDERS EQUITY
Retained Earnings -$374.3M -$369.0M
YoY Change 10.89%
Common Stock $90.97K $74.36K
YoY Change 28.87%
Preferred Stock
YoY Change
Treasury Stock (at cost) $85.19K $85.19K
YoY Change 0.0%
Treasury Stock Shares 22.00 shares
Shareholders Equity $26.65M $29.33M $29.33M
YoY Change
Total Liabilities & Shareholders Equity $42.11M $43.98M $43.98M
YoY Change -34.56% -40.61% -40.61%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$5.591M -$13.23M -$35.90M
YoY Change -46.62% 213.41% 72.84%
Depreciation, Depletion And Amortization $192.7K $220.0K $731.6K
YoY Change 10.74% 37.35% 4.08%
Cash From Operating Activities -$4.086M -$5.060M -$23.13M
YoY Change -48.78% -0.55% 42.58%
INVESTING ACTIVITIES
Capital Expenditures $57.14K $50.00K $267.8K
YoY Change -202.24% -295.01% -185.94%
Acquisitions
YoY Change
Other Investing Activities $580.0K -$10.79M $8.580M
YoY Change -96.55% 1037.18% -128.78%
Cash From Investing Activities $519.3K -$10.83M $8.315M
YoY Change -96.9% 1011.36% -127.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.723M
YoY Change -87.6%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $2.474M 440.0K $6.723M
YoY Change -87.73%
NET CHANGE
Cash From Operating Activities -$4.086M -5.060M -$23.13M
Cash From Investing Activities $519.3K -10.83M $8.315M
Cash From Financing Activities $2.474M 440.0K $6.723M
Net Change In Cash -$1.092M -15.45M -$8.093M
YoY Change 154.84% -196.1%
FREE CASH FLOW
Cash From Operating Activities -$4.086M -$5.060M -$23.13M
Capital Expenditures $57.14K $50.00K $267.8K
Free Cash Flow -$4.143M -$5.110M -$23.40M
YoY Change -47.7% 0.94% 47.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000749647
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Other Short Term Investments
OtherShortTermInvestments
usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
usd
CY2021 us-gaap Payments For Repurchase Of Redeemable Convertible Preferred Stock
PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2022 IMNN Proceeds From Issuance Of Common Stock Upon Exercise Of Stock Options
ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptions
usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2022 IMNN Payments On Notes Payable Including Endofterm Fees
PaymentsOnNotesPayableIncludingEndoftermFees
usd
CY2022 IMNN Stock Issued During Period Value Reverse Stock Splits
StockIssuedDuringPeriodValueReverseStockSplits
usd
CY2022 IMNN Stock Issued During Period Value Issuance Of Preferred Stock Upon Financing
StockIssuedDuringPeriodValueIssuanceOfPreferredStockUponFinancing
usd
CY2022 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
pure
CY2022Q4 IMNN Earnout Milestone Liability
EarnoutMilestoneLiability
usd
CY2022Q4 IMNN Lessee Operating Lease Liability Payments Due After Year One And There After
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearOneAndThereAfter
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-15911
CY2022 dei Entity Registrant Name
EntityRegistrantName
IMUNON, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-1256615
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
997 LENOX DRIVE
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE 100
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
LAWRENCEVILLE
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08648
CY2022 dei City Area Code
CityAreaCode
(609)
CY2022 dei Local Phone Number
LocalPhoneNumber
896-9100
CY2022 dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.01 Per Share
CY2022 dei Trading Symbol
TradingSymbol
IMNN
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
13100000 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9089789 shares
CY2022 dei Auditor Name
AuditorName
WithumSmith+Brown, PC
CY2022 dei Auditor Location
AuditorLocation
Princeton, New Jersey
CY2022 dei Auditor Firm
AuditorFirmId
100
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11492841 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19586272 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
21254485 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
29803095 usd
CY2022Q4 us-gaap Debt Securities Held To Maturity Accrued Interest After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss
128932 usd
CY2021Q4 us-gaap Debt Securities Held To Maturity Accrued Interest After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss
108844 usd
CY2022Q4 us-gaap Other Short Term Investments
OtherShortTermInvestments
1500000 usd
CY2022Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
2778433 usd
CY2021Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
2447413 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
37154691 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
51945624 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
548301 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
477011 usd
CY2022Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
4500000 usd
CY2021Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
6000000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1567026 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1383446 usd
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
13366234 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
155876 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
690995 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
50000 usd
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
183489 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6272902 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21624164 usd
CY2022Q4 us-gaap Assets
Assets
43975894 usd
CY2021Q4 us-gaap Assets
Assets
74046799 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3586623 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2547251 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4794936 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3173537 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1424774 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
230749 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
548870 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
500000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10037082 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6769658 usd
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5396000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
4610946 usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
5854461 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
230749 usd
CY2022Q4 us-gaap Liabilities
Liabilities
14648028 usd
CY2021Q4 us-gaap Liabilities
Liabilities
18250868 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
112500000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
112500000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7436219 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5770538 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7436197 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5770516 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
74362 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
57705 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
397980023 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
388600979 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
26494 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7974 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-368667825 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-332769591 usd
CY2022Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
29413054 usd
CY2021Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
55881119 usd
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
22 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
22 shares
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
85188 usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
85188 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
29327866 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
55795931 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43975894 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74046799 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
500000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
500000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11733666 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10619287 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13687899 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10887903 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
25421565 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
21507190 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-24921565 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-21007190 usd
CY2022 IMNN Gain Loss From Change In Earnout Milestone Liability
GainLossFromChangeInEarnoutMilestoneLiability
5396000 usd
CY2021 IMNN Gain Loss From Change In Earnout Milestone Liability
GainLossFromChangeInEarnoutMilestoneLiability
1622000 usd
CY2022 IMNN Impairment Of Goodwill And Inprocess Research And Development
ImpairmentOfGoodwillAndInprocessResearchAndDevelopment
13366234 usd
CY2021 IMNN Impairment Of Goodwill And Inprocess Research And Development
ImpairmentOfGoodwillAndInprocessResearchAndDevelopment
1976101 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-234419 usd
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
453356 usd
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
10996 usd
CY2022 us-gaap Interest Expense
InterestExpense
5028618 usd
CY2021 us-gaap Interest Expense
InterestExpense
569881 usd
CY2022 us-gaap Other Income
OtherIncome
1801 usd
CY2021 us-gaap Other Income
OtherIncome
1899 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12543695 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1145506 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37465260 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22152696 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1567026 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1383446 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-35898234 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-20769250 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.03
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.83
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7142970 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5426953 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-35898234 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-20769250 usd
CY2022 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-43508 usd
CY2021 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-7149 usd
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-17014 usd
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
825 usd
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
26494 usd
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
7974 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35871740 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20761276 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-35898234 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-20769250 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
731629 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
702918 usd
CY2022 IMNN Gain Loss From Change In Earnout Milestone Liability
GainLossFromChangeInEarnoutMilestoneLiability
5396000 usd
CY2021 IMNN Gain Loss From Change In Earnout Milestone Liability
GainLossFromChangeInEarnoutMilestoneLiability
1622000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
2673034 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
3759737 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
462377 usd
CY2022 IMNN Impairment Of Goodwill And Inprocess Research And Development
ImpairmentOfGoodwillAndInprocessResearchAndDevelopment
13366234 usd
CY2021 IMNN Impairment Of Goodwill And Inprocess Research And Development
ImpairmentOfGoodwillAndInprocessResearchAndDevelopment
1976101 usd
CY2022 IMNN Amortization Of Deferred Finance Charges And Debt Discount Associated With Note Payable
AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable
181259 usd
CY2021 IMNN Amortization Of Deferred Finance Charges And Debt Discount Associated With Note Payable
AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable
237258 usd
CY2022 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
20088 usd
CY2021 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
108844 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
514600 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
786718 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-133489 usd
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
124728 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1039372 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
302404 usd
CY2022 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1072529 usd
CY2021 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
247142 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-500000 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-500000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23131376 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16223603 usd
CY2022 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
48191922 usd
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
53811069 usd
CY2022 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
56775000 usd
CY2021 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
24000000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
267800 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
311613 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8315278 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30122682 usd
CY2022 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
28500000 usd
CY2022 us-gaap Payments For Repurchase Of Redeemable Convertible Preferred Stock
PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
28500000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6722667 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
52688946 usd
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1508666 usd
CY2021 IMNN Proceeds From Issuance Of Common Stock Upon Exercise Of Stock Options
ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptions
4725 usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
5756630 usd
CY2021 IMNN Payments On Notes Payable Including Endofterm Fees
PaymentsOnNotesPayableIncludingEndoftermFees
5190587 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6722667 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54768380 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8093431 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8422095 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25586272 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17164177 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17492841 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25586272 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
4847359 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
357277 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
601495 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
568269 usd
CY2022 IMNN Realized And Unrealized Gains And Losses Net On Investment In Debt Securities
RealizedAndUnrealizedGainsAndLossesNetOnInvestmentInDebtSecurities
26494 usd
CY2021 IMNN Realized And Unrealized Gains And Losses Net On Investment In Debt Securities
RealizedAndUnrealizedGainsAndLossesNetOnInvestmentInDebtSecurities
7974 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
55795931 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-35898234 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6722654 usd
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
13 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
34468 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2673034 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
29327866 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
18611081 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-20769250 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
52688946 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4725 usd
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1508666 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7974 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3759737 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
55795931 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
21254485 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zU3TthjR0Iib" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zTQbtXLALHba">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the reported amounts of expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On an ongoing basis, the Company evaluates its estimates using historical experience and other factors, including the current economic environment. Significant items subject to such estimates are assumptions used for purposes of determining stock-based compensation, the fair value of the earn-out milestone liabilities, estimates for contingent liabilities, if any, and accounting for impairment of in-process research and development assets and goodwill evaluation. Management believes its estimates to be reasonable under the circumstances. Actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
29803095 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
21227991 usd
CY2022 us-gaap Depreciation
Depreciation
197000 usd
CY2021 us-gaap Depreciation
Depreciation
130000 usd
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
21254485 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
29811069 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
29803095 usd
CY2022 IMNN Number Of Shares Of Common Stock Issuable Upon Exercise Of Warrants And Equity Awards
NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards
988389 shares
CY2021 IMNN Number Of Shares Of Common Stock Issuable Upon Exercise Of Warrants And Equity Awards
NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards
618800 shares
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-369000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
32800000 usd
CY2022 IMNN Proceeds From Sale Of Net Operating Losses
ProceedsFromSaleOfNetOperatingLosses
1600000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
6000000.0 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1600000 usd
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1400000 usd
CY2022Q4 IMNN Debt Securities Availableforsale Maturity Allocated And Single Maturity Date Rolling Within Three Months Amortized Cost
DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost
4005559 usd
CY2022Q4 IMNN Debt Securities Availableforsale Maturity Allocated And Single Maturity Date Rolling Within Three Months Fair Value
DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue
3994590 usd
CY2021Q4 IMNN Debt Securities Availableforsale Maturity Allocated And Single Maturity Date Rolling Within Three Months Amortized Cost
DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost
19798177 usd
CY2021Q4 IMNN Debt Securities Availableforsale Maturity Allocated And Single Maturity Date Rolling Within Three Months Fair Value
DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue
19799835 usd
CY2022Q4 IMNN Debt Securities Availableforsale Maturity Allocated And Single Maturity Date Rolling Between Three And Twelve Months Amortized Cost
DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost
17222432 usd
CY2022Q4 IMNN Debt Securities Availableforsale Maturity Allocated And Single Maturity Date Rolling Between Three And Twelve Months Fair Value
DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue
17259895 usd
CY2021Q4 IMNN Debt Securities Availableforsale Maturity Allocated And Single Maturity Date Rolling Between Three And Twelve Months Amortized Cost
DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost
10012892 usd
CY2021Q4 IMNN Debt Securities Availableforsale Maturity Allocated And Single Maturity Date Rolling Between Three And Twelve Months Fair Value
DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue
10003260 usd
CY2022Q4 IMNN Available For Sale Debt Securities Amortized Cost Basis Current
AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent
21227991 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
21254485 usd
CY2021Q4 IMNN Available For Sale Debt Securities Amortized Cost Basis Current
AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent
29811069 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
29803095 usd
CY2022Q4 IMNN Available For Sale Securities Unrealized Gains Fair Value
AvailableForSaleSecuritiesUnrealizedGainsFairValue
13278505 usd
CY2022Q4 IMNN Available For Sale Securities Unrealized Holding Gains Less Than Twelve Months
AvailableForSaleSecuritiesUnrealizedHoldingGainsLessThanTwelveMonths
43508 usd
CY2021Q4 IMNN Available For Sale Securities Unrealized Gains Fair Value
AvailableForSaleSecuritiesUnrealizedGainsFairValue
8999580 usd
CY2021Q4 IMNN Available For Sale Securities Unrealized Holding Gains Less Than Twelve Months
AvailableForSaleSecuritiesUnrealizedHoldingGainsLessThanTwelveMonths
3499 usd
CY2022Q4 IMNN Available For Sale Securities Unrealized Loss Fair Value
AvailableForSaleSecuritiesUnrealizedLossFairValue
7975980 usd
CY2022Q4 IMNN Available For Sale Securities Unrealized Holding Losses Less Than Twelve Months
AvailableForSaleSecuritiesUnrealizedHoldingLossesLessThanTwelveMonths
-17014 usd
CY2021Q4 IMNN Available For Sale Securities Unrealized Loss Fair Value
AvailableForSaleSecuritiesUnrealizedLossFairValue
20803515 usd
CY2021Q4 IMNN Available For Sale Securities Unrealized Holding Losses Less Than Twelve Months
AvailableForSaleSecuritiesUnrealizedHoldingLossesLessThanTwelveMonths
-11473 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
21254485 usd
CY2022Q4 IMNN Available For Sale Securities Unrealized Holding Gains Losses Less Than Twelve Months
AvailableForSaleSecuritiesUnrealizedHoldingGainsLossesLessThanTwelveMonths
26494 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
29803095 usd
CY2021Q4 IMNN Available For Sale Securities Unrealized Holding Gains Losses Less Than Twelve Months
AvailableForSaleSecuritiesUnrealizedHoldingGainsLossesLessThanTwelveMonths
-7974 usd
CY2022 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
502578 usd
CY2021 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
18145 usd
CY2022 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-49222 usd
CY2021 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-7149 usd
CY2022 IMNN Investment Income Loss Nonoperating
InvestmentIncomeLossNonoperating
453356 usd
CY2021 IMNN Investment Income Loss Nonoperating
InvestmentIncomeLossNonoperating
10996 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
35720 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
5964280 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
70128000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
91519974 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11492841 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19586272 usd
CY2022Q4 us-gaap Restricted Investments
RestrictedInvestments
6000000 usd
CY2021Q4 us-gaap Restricted Investments
RestrictedInvestments
6000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17492841 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25586272 usd
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
2000000.0 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3192063 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3832749 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2643762 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3355738 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
548301 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
477011 usd
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
2196711 usd
CY2021Q4 us-gaap Contractual Obligation
ContractualObligation
1401356 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2139927 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1636727 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
37583 usd
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
16792 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
215402 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
87250 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
205313 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
31412 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4794936 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3173537 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1500000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3000000 usd
CY2022Q4 IMNN Long Term Debt Maturities Repayments Of Principal Year Four And There After
LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereAfter
1500000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6000000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1567026 usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1383446 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1567026 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1383446 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.071 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.078 pure
CY2022 IMNN Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.298 pure
CY2021 IMNN Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.150 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.538 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.076 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.046 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.062 pure
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
79800000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
64915000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
13287000 usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
5213000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
93087000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
168519 shares
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
68744554 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1567026 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1383446 usd
CY2021 IMNN Net Operating Losses Carryforward Limits Description
NetOperatingLossesCarryforwardLimitsDescription
the deduction for net operating losses incurred in tax years beginning after January 1, 2018 is limited to 80% of annual taxable income. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted in response to the COVID-19 pandemic. The CARES Act provides for economic and cash liquidity stimulus through various means including payroll tax credits, payroll tax deferral, short-term changes in tax deductibility of interest expenses among other things. The Act also permits NOL carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021. Previously, NOLs generated after December 31, 2017 were limited to 80% of taxable income in future years. In addition, the CARES Act allows NOLs incurred in 2018 through 2021 to be carried back to each of the five preceding tax years. The Company evaluated the various aspects of the Cares Act and determined that there was no material effect on the Financial Statements.
CY2021 IMNN Net Operating Losses Expiration Description
NetOperatingLossesExpirationDescription
expire starting in 2029 through 2041
CY2011Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
4200000 usd
CY2011Q3 IMNN Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
90000000 usd
CY2013Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1400000 usd
CY2013Q1 IMNN Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
34000000 usd
CY2013Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1500000 usd
CY2013Q2 IMNN Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
4000000 usd
CY2015Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1600000 usd
CY2015Q2 IMNN Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
40000000 usd
CY2017Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
300000 usd
CY2017Q1 IMNN Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
35000000 usd
CY2017Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
300000 usd
CY2017Q2 IMNN Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
7000000 usd
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
800000 usd
CY2017Q4 IMNN Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
5000000 usd
CY2018Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1500000 usd
CY2018Q3 IMNN Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
30000000 usd
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
800000 usd
CY2018Q3 IMNN Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
15000000 usd
CY2020Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2000000.0 usd
CY2021Q1 IMNN Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
40000000 usd
CY2021Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
28000000.0 usd
CY2021Q1 IMNN Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
30000000 usd
CY2021Q1 IMNN Shelf Registration Statement Amount
ShelfRegistrationStatementAmount
100000000 usd
CY2022 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On February 28, 2022, the Company effected a 15-for-1 reverse stock split of its common stock which was made effective for trading purposes as of the commencement of trading on March 31, 2022. As of that date, each 15 shares of issued and outstanding common stock and equivalents was consolidated into one share of common stock. All shares have been restated to reflect the effects of the 15-for-1 reverse stock split. In addition, at the market open on March 1, 2022, the Company’s common stock started trading under a new CUSIP number 15117N602 although the Company’s ticker symbol, CLSN, remained unchanged.
CY2022Q4 IMNN Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
19.78
CY2022Q4 IMNN Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue
0 usd
CY2022 IMNN Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
4059 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
31.05
CY2020Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
213333 shares
CY2021 us-gaap Stockholders Equity Note Changes In Capital Structure Retroactive Impact
StockholdersEquityNoteChangesInCapitalStructureRetroactiveImpact
To continue listing on The NASDAQ Capital Market, which requires that the Company comply with the applicable listing requirements under NASDAQ Marketplace Rules, which requirements include, among others, a minimum bid price of at least $1.00 per share. On December 2, 2021, the Company received a letter from NASDAQ indicating that the closing bid price of the Company’s Common Stock fell below $1.00 per share for the previous 30 consecutive business days, and that the Company was therefore not in compliance with the minimum bid price requirement for continued inclusion on The NASDAQ Capital Market. The Company had 180 calendar days, until May 31, 2022, to regain compliance with this requirement, which occurs when the closing bid price of the Company’s Common Stock is at least $1.00 per share for a minimum of ten consecutive business days during the 180-day compliance period
CY2022 us-gaap Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares
StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares
5770516 shares
CY2022Q1 us-gaap Share Price
SharePrice
285
CY2022Q1 IMNN Original Issue Discount Rate
OriginalIssueDiscountRate
5 pure
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
300
CY2022Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
14250000 usd
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
300
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1000000 usd
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
83 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
9.45
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1464 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.48
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
66 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
33.30
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1481 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
12.36
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
69650 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.92
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1381 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
12.04
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
100 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
9.45
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
69650 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.92
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
760220 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
201935 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0174 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0397 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0154 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0174 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.000 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.139 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.068 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.132 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
700000 usd
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2020Q4 IMNN Earnout Milestone Liability
EarnoutMilestoneLiability
7018000 usd
CY2021 IMNN Gain Loss From Change In Fair Value Of Earn Out Milestone Liability
GainLossFromChangeInFairValueOfEarnOutMilestoneLiability
1622000 usd
CY2021Q4 IMNN Earnout Milestone Liability
EarnoutMilestoneLiability
5396000 usd
CY2022 IMNN Gain Loss From Change In Fair Value Of Earn Out Milestone Liability
GainLossFromChangeInFairValueOfEarnOutMilestoneLiability
5396000 usd
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
256903 shares
CY2020Q4 IMNN Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
20.10
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
81111 shares
CY2021 IMNN Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercise In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExerciseInPeriodWeightedAverageExercisePrice
18.60
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
175792 shares
CY2021Q4 IMNN Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
20.96
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
7273 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
48.30
CY2022 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.03 pure
CY2022 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
117000 usd
CY2021 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
107000 usd
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
172000 usd
CY2021 IMNN Defined Contribution Plan Employer Discretionary Contribution Percent
DefinedContributionPlanEmployerDiscretionaryContributionPercent
0.05 pure
CY2011 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
In 2011, the Company executed a lease (the “Lease”) with Brandywine Operating Partnership, L.P. (Brandywine), a Delaware limited partnership, for a 10,870 square foot premises located in Lawrenceville, New Jersey and relocated its offices to Lawrenceville, New Jersey from Columbia, Maryland. The Lease had an initial term of 66 months. In late 2015, Lenox Drive Office Park LLC, purchased the real estate and office building and assumed the Lease.
CY2011Q4 us-gaap Area Of Land
AreaOfLand
10870
CY2011Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P66M
CY2011Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2017-04-30
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
238609 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
238609 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7860 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
230749 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y7M9D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0998 pure

Files In Submission

Name View Source Status
0001493152-23-009604-index-headers.html Edgar Link pending
0001493152-23-009604-index.html Edgar Link pending
0001493152-23-009604.txt Edgar Link pending
0001493152-23-009604-xbrl.zip Edgar Link pending
ex10-25.htm Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
imnn-20221231.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
imnn-20221231_def.xml Edgar Link unprocessable
imnn-20221231_lab.xml Edgar Link unprocessable
imnn-20221231_cal.xml Edgar Link unprocessable
imnn-20221231_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending